IGHMBP2 and Charcot-Marie-Tooth disease axonal type 2S: However, since the clinical diagnostic criteria of SMARD1 and CMT2S are partly parallel, and there might be modifier genes affecting the phenotype expression, we suggested that SMARD1 and CMT2S can be of a phenotypic spectrum instead of two completely different diagnoses.